TELK -- Telik, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TELK -- Telik, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	10/15/2007 7:59:35 AM
	of 887

Telik: FDA removes hold on drug trial By Michelle Donley Last Update: 7:45 AM ET Oct 15, 2007 NEW YORK (MarketWatch) -- Telik Inc. (TELK marketwatch.com TELK) said Monday that the U.S. Food and Drug Administration lifted a partial hold on clinical trials for cancer drug Telcyta, allowing clinical development of the drug to resume. In early June, the FDA asked the Palo Alto, Calif.-based biopharmaceutical company to temporarily halt clinical trials for Telcyta, which is a potential treatment for ovarian and lung cancer, over safety concerns; the drug did not fare well in three Phase III trials. Shares of Telik closed Friday at $3.46

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next